AbbVie Inc. (ABBV) Stock buybacks 2016–2025
AbbVie Inc. (ABBV) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$980.0MFY2025 · since FY2016: $6.0B → $980.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $980.0M | -42.6% |
| FY2024 | $1.7B | -13.4% |
| FY2023 | $2.0B | +32.6% |
| FY2022 | $1.5B | +59.2% |
| FY2021 | $934.0M | -4.5% |
| FY2020 | $978.0M | +55.5% |
| FY2019 | $629.0M | -94.8% |
| FY2018 | $12.0B | +752.1% |
| FY2017 | $1.4B | -76.6% |
| FY2016 | $6.0B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ABBV financial trends
ABBV RevenueABBV Net incomeABBV Net marginABBV Gross profitABBV Gross marginABBV Operating incomeABBV Operating marginABBV Operating cash flowABBV Free cash flowABBV Capital expendituresABBV Return on equityABBV Dividends paidABBV Total assetsABBV Total liabilitiesABBV Shareholders’ equityABBV overview →